Silexion Therapeutics Corp

Nasdaq:SLXNNasdaq:SLXNW

Biological Products, (No Diagnostic Substances)·RAMAT GAN, L3

CEO

Hadar Ilan

CFO

Horenshtein Hadar Mirit

Financials

6 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/18/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/29/24	→

Earnings Releases (8-K)

6 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/18/25	Q1 FY2025	→
1/14/25	Q4 FY2025	→
11/14/24	Q4 FY2024	→

News (8-K)

50 shown

Filed	Type	Description
2/3/26	Reg FD	Regulation FD Disclosure	→
1/6/26	Reg FD	Regulation FD Disclosure	→
12/16/25	Reg FD	Regulation FD Disclosure	→
12/2/25	Reg FD	Regulation FD Disclosure	→
11/25/25	Reg FD	Regulation FD Disclosure	→
9/30/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/19/26	S-8	S-8	→
10/31/25	S-3	S-3	→
9/26/25	S-3	S-3	→
9/12/25	424B4	424B4	→
9/5/25	S-1	S-1	→
9/4/25	424B3	424B3	→
↓

Filing History(206 filings)

TypeDateAccessionPeriodSize

Feb 25, 2026

0001178913-26-000644

Feb 20, 2026

17.4 KB

Feb 23, 2026

0001178913-26-000606

Feb 20, 2026

16.4 KB

Feb 23, 2026

0001178913-26-000604

Feb 20, 2026

14.0 KB

Feb 23, 2026

0001178913-26-000602

Feb 20, 2026

5.3 KB

Feb 23, 2026

0001178913-26-000600

Feb 20, 2026

14.0 KB

Feb 23, 2026

0001178913-26-000598

Feb 20, 2026

16.3 KB

Feb 23, 2026

0001178913-26-000596

Feb 20, 2026

16.2 KB

Feb 23, 2026

0001178913-26-000594

Feb 20, 2026

17.4 KB

DEF 14A

Feb 23, 2026

0001178913-26-000593DEF 14A

Feb 23, 2026

1.7 MB

S-8

Feb 19, 2026

0001178913-26-000574S-8

—

1.7 MB

SCHEDULE 13G/A

Feb 13, 2026

0001213900-26-016532

—

10.9 KB

PRE 14A

Feb 13, 2026

0001178913-26-000471PRE 14A

Feb 13, 2026

826.2 KB

8-K

Feb 3, 2026

0001178913-26-0002898-K

Feb 3, 2026

5.3 MB

Jan 27, 2026

0001178913-26-000228

Aug 7, 2025

14.8 KB

8-K

Jan 6, 2026

0001178913-26-0000678-K

Jan 6, 2026

277.0 KB

Dec 31, 2025

0001178913-25-004151

Feb 9, 2025

16.0 KB

Dec 31, 2025

0001178913-25-004149

Feb 9, 2025

16.1 KB

Dec 31, 2025

0001178913-25-004147

Feb 9, 2025

17.8 KB

Dec 31, 2025

0001178913-25-004145

Feb 9, 2025

17.8 KB

Dec 31, 2025

0001178913-25-004143

Feb 9, 2025

15.3 KB

8-K

Dec 16, 2025

0001178913-25-0040678-K

Dec 16, 2025

251.9 KB

8-K

Dec 2, 2025

0001178913-25-0039818-K

Dec 2, 2025

256.3 KB

8-K

Nov 25, 2025

0001178913-25-0039498-K

Nov 25, 2025

256.5 KB

SCHEDULE 13G/A

Nov 14, 2025

0000929638-25-004297

—

10.0 KB

8-K

Nov 12, 2025

0001178913-25-0037568-K

Nov 12, 2025

449.2 KB

25 filings shown

Silexion Therapeutics Corp

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(206 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/23/26	DEF 14A	DEF 14A	→
2/13/26	PRE 14A	PRE 14A	→
8/12/25	DEFA14A	DEFA 14A	→
7/31/25	DEF 14A	DEF 14A	→
7/21/25	PRE 14A	PRE 14A	→
7/7/25	DEFA14A	DEFA 14A	→
↓

Filed	Form	Description
2/25/26	4	4	→
2/23/26	4	4	→
2/23/26	4	4	→
2/23/26	4	4	→
2/23/26	4	4	→
2/23/26	4	4	→
↓